The potential therapeutic use of A2AR agonists and antagonists for specific conditions such as Niemann Pick disease, schizophrenia, autism-spectrum disorders, depression, anxiety, Alzheimer’s disease, attention-deficit hyperactivity disorder, PD, and fragile X syndrome is comprehensively discussed in the literature [122]. This evidence concerns the gene ADORA2A and schizophrenia.